azacitidine and venetoclax maintenance post allosct in high-risk t-all
Published 1 year ago • 145 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:12
phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
2:27
low-dose azacitidine and venetoclax as maintenance therapy in patients with aml
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
4:52
apoptosis and venetoclax
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
4:51
the current frontline treatment strategy in multiple myeloma
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
1:23
azacitidine and venetoclax /- gemtuzumab ozogamicin in pediatric patients with r/r acute leukemias
-
1:56
evaluating long-term survival in patients with aml who discontinued azacitidine-venetoclax
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
5:52
venetoclax in combination with azacitidine for patients with treatment-naïve hr-mds
-
1:24
omniverse: safety and tolerability of oral azacitidine plus venetoclax in patients with aml
-
2:20
pevonedistat, azacitidine and venetoclax triplet therapy for aml, mds and cmml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
2:43
venetoclax azacitidine in unfit patients with aml
-
1:57
venetoclax and azacitidine for aml ineligible for standard induction